Bryan H. Goldstein, MD, FACC, FSCAI, FAAP

Associate Director, Cardiac Catheterization Laboratory

Academic Affiliations

Associate Professor, UC Department of Pediatrics

Phone 513-636-7072

Fax 513-636-2410

Email bryan.goldstein@cchmc.org

Clinical

Cardiac catheterization; intervention for congenital heart disease; transcatheter valve implantation; single ventricle physiology; interventional catheterization; General Cardiology Outpatient Clinic; Interstage Program

Research

Congenital heart disease outcomes research; novel transcatheter interventions (including hybrid therapies); single ventricle physiology (including Fontan); vascular endothelial function; ventricular mechanics and diastolic function; renal injury in congenital heart disease

Bryan H. Goldstein, MD, FACC, FSCAI, FAAP, joined the Heart Institute in 2011 in the section of Cardiac Catheterization and Intervention. A native of Boston, Mass., Dr. Goldstein graduated with honors from Amherst College, where he was a goalie on the men's lacrosse team. He earned his medical degree with honors from Boston University School of Medicine. He completed his pediatric residency at Children's Hospital Boston (BCRP) and his pediatric and interventional cardiology fellowships at the University of Michigan (C.S. Mott Children's Hospital) in Ann Arbor.

Dr. Goldstein’s clinical expertise is in congenital cardiac catheterization. He is interested in invasive physiologic assessment of complex congenital heart disease (CHD), including single ventricle physiology, as well as minimally invasive transcatheter therapies. Dr. Goldstein has particular clinical interests in transcatheter valve therapy and innovative hybrid therapies

Dr. Goldstein’s research interests include novel transcatheter interventions and long-term outcomes following interventions for CHD. An additional research focus includes long-term functional outcomes in Fontan survivors, including investigations of vascular function and ventricular diastolic function in the Fontan population. Dr. Goldstein receives grant funding from the American Heart Association and NHLBI. He is a co-investigator for the Nit-Occlud® PDA Post-Approval Study and previously served as a co-investigator for the Melody™ Transcatheter Pulmonary Valve Post-Approval Study.

Dr. Goldstein is a fellow of the American College of Cardiology (FACC), the Society of Cardiovascular Angiography and Interventions (FSCAI), and the American Academy of Pediatrics (FAAP) and an active member of the American Heart Association (AHA). He received the Pediatric Interventional Cardiology Symposium Young Leadership Award in 2013 and was recently honored with election to the Emerging Leader Mentorship program 2015-2017 through SCAI, ACC and CRF.

MD: Boston University School of Medicine, Boston, MA, 2004.

Residency: Pediatrics, Children’s Hospital Boston, Boston, MA, 2007. 

Fellowship: Pediatric Cardiology, C.S. Mott Children’s Hospital, Ann Arbor, MI, 2010.

Advanced Fellowship: Interventional Cardiology, C.S. Mott Children’s Hospital, Ann Arbor, MI, 2011.

Certifications: Pediatrics, 2007; Pediatric Cardiology, 2010. 

View PubMed Publications

Averin K, Bucuvalas J, Alonso MH, Kohli R, Heubi JE, Johnson ND, Goldstein BH. Treatment of Inferior Vena Cava Obstruction Following Pediatric Liver Transplantation: Novel Use of a Customized Endovascular Stent. J Pediatr. 2016 Oct 25.

Goldstein BH, Urbina EM, Khoury PR, Gao Z, Amos MA, Mays WA, Redington AN, Marino BS. Endothelial Function and Arterial Stiffness Relate to Functional Outcomes in Adolescent and Young Adult Fontan Survivors. J Amer Heart Assoc. 2016 Sep 24;5(9).

McElhinney DB, Cabalka AK, Aboulhosn JA, Eicken A, Boudjemline Y, Schubert S, Himbert D, Asnes JD, Salizzoni S, Bocks ML, Cheatham JP, Momenah TS, Kim DW, Schranz D, Meadows J, Thomson J, Goldstein BH, Lucas VW, Fagan TE, Webb JG, Horlick E, Delaney JW, Jones TK, Shahanavaz S, Alfonsi J, Hainstock MR, Kenny DP, Berger FP, Rihal CS, Dvir D for the VIVID Registry. Transcatheter Tricuspid Valve-in-Valve Implantation for the Treatment of Dysfunctional Surgical Bioprosthetic Valves: An International Multicenter Registry Study. Circulation. 2016 Apr 19;133(16):1582-93.

Averin K, Hirsch R, Seckeler MD, Beekman RH III, Goldstein BH. Diagnosis of Occult Diastolic Dysfunction Late After the Fontan Procedure Using a Rapid Volume Expansion Technique. Heart. 2016 Jul 15;102(14):1109-14.

Goldstein BH, Holzer RJ, Trucco SM, Porras D, Murphy J, Foerster S, El-Said HG, Beekman RH III, Bergersen L. Practice Variation in Single Ventricle Patients Undergoing Elective Cardiac Catheterization: A Report from the Congenital Cardiac Catheterization Project on Outcomes (C3PO). Congenit Heart Dis. 2016;11:122-35.  

Seckeler M, Hirsch R, Beekman RH III, Goldstein BH. A New Predictive Equation for Oxygen Consumption in Children and Adults with Congenital and Acquired Heart Disease. Heart. 2015 Apr 1;101(7)517-24.

Goldstein BH, Hirsch R, Zussman M, Vincent JA, Torres A, Coulson J, Ringel RE, Beekman RH III. Percutaneous Balloon-Expandable Covered Stent Implantation for Treatment of Traumatic Aortic Injury in Children and Adolescents. Am J Cardiol. 2012 Nov 15;110(10):1541-5.

Goldstein BH, Fifer CG, Armstrong AK, Gelehrter SK, Treadwell MC, van de Ven C, Rocchini AP. Use of a Pressure Guidewire in Fetal Cardiac Intervention for Critical Aortic Stenosis. Pediatrics. 2011 Aug 15.

Goldstein BH, Golbus JR, Sandelin AM, Warnke N, Gooding L, King KK, Donohue JE, Gurney JG, Goldberg CS, Rocchini AP, Charpie JR. Usefulness of Peripheral Vascular Function to Predict Functional Health Status in Patients with a Fontan Circulation. Am J Cardiol. 2011 Aug 1;108(3):428-34.

Goldstein BH, Connor C, Gooding L, Rocchini AP. Relation of Systemic Venous Return, Diastolic Dysfunction and Pulmonary Vascular Resistance to Exercise Capacity in Patients with Single Ventricle Receiving Fontan Palliation. Am J Cardiol. 2010 Apr 15;105(8):1169-75.